Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Freedman

Showing results (91-100 of 1,513) with videos related to

Pageof 152
Sort By:
Development (Cambridge, England)|May 6, 2020
Once upon a dish: engineering multicellular systemsKristina Haase, Benjamin S Freedman
Cancer Chemotherapy and Pharmacology|January 1, 1988
When can the infusion period be safely ignored in the estimation of pharmacokinetic parameters of drugs in humans?L S Freedman, P Workman
Journal of the National Cancer Institute|November 27, 2008
Impact of exposure measurement error in nutritional epidemiologyVictor Kipnis, Laurence S Freedman
Pediatrics|September 2, 2009
The validity of BMI as an indicator of body fatness and risk among childrenDavid S Freedman, Bettylou Sherry
Clinical Neurology and Neurosurgery|April 6, 2010
Therapy of MSReza Vosoughi, Mark S Freedman
American Journal of Epidemiology|November 1, 1992
Sample size for studying intermediate endpoints within intervention trails or observational studiesL S Freedman, A Schatzkin
The Lancet. Neurology|January 13, 2012
Neurorepair with mesenchymal stem cells: hope or hype?Mark S Freedman, Antonio Uccelli
BMJ (Clinical Research Ed.)|April 4, 1992
Injuries sustained on "bouncy castles"G Singer, L S Freedman
Biometrics|June 1, 1997
Bayesian design and analysis of two x two factorial clinical trialsR Simon, L S Freedman
ACS Central Science|April 3, 2019
Building Scaffolds To Rebuild KidneysBenjamin S Freedman, Buddy Ratner
Pageof 152

Showing results (91-100 of 1,513) with videos related to

Sort By:
Pageof 152
Development (Cambridge, England)|May 6, 2020
Once upon a dish: engineering multicellular systemsKristina Haase, Benjamin S Freedman
Cancer Chemotherapy and Pharmacology|January 1, 1988
When can the infusion period be safely ignored in the estimation of pharmacokinetic parameters of drugs in humans?L S Freedman, P Workman
Journal of the National Cancer Institute|November 27, 2008
Impact of exposure measurement error in nutritional epidemiologyVictor Kipnis, Laurence S Freedman
Pediatrics|September 2, 2009
The validity of BMI as an indicator of body fatness and risk among childrenDavid S Freedman, Bettylou Sherry
Clinical Neurology and Neurosurgery|April 6, 2010
Therapy of MSReza Vosoughi, Mark S Freedman
American Journal of Epidemiology|November 1, 1992
Sample size for studying intermediate endpoints within intervention trails or observational studiesL S Freedman, A Schatzkin
The Lancet. Neurology|January 13, 2012
Neurorepair with mesenchymal stem cells: hope or hype?Mark S Freedman, Antonio Uccelli
BMJ (Clinical Research Ed.)|April 4, 1992
Injuries sustained on "bouncy castles"G Singer, L S Freedman
Biometrics|June 1, 1997
Bayesian design and analysis of two x two factorial clinical trialsR Simon, L S Freedman
ACS Central Science|April 3, 2019
Building Scaffolds To Rebuild KidneysBenjamin S Freedman, Buddy Ratner
Pageof 152